Page last updated: 2024-08-23

fludrocortisone and Hypertrophy, Left Ventricular

fludrocortisone has been researched along with Hypertrophy, Left Ventricular in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (66.67)	29.6817
2010's	1 (33.33)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Baran, A; Karapinar, H; Karavelioglu, Y; Küçükdurmaz, Z; Yilmaz, A	1
Kaufmann, H; Phillips, RA; Saadia, D; Tuhrim, S; Vagaonescu, TD	1
Perazella, MA	1

Reviews

1 review(s) available for fludrocortisone and Hypertrophy, Left Ventricular

Article	Year
Pharmacologic options available to treat symptomatic intradialytic hypotension. American journal of kidney diseases : the official journal of the National Kidney Foundation, 2001, Volume: 38, Issue:4 Suppl 4 Topics: Adrenergic Agents; Autonomic Nervous System; Caffeine; Carnitine; Ephedrine; Fludrocortisone; Hemodiafiltration; Humans; Hypertrophy, Left Ventricular; Hypotension; Kidney Failure, Chronic; Midodrine; Renal Dialysis; Risk Factors; Selective Serotonin Reuptake Inhibitors; Sertraline	2001

Article

Year

Pharmacologic options available to treat symptomatic intradialytic hypotension.

American journal of kidney diseases : the official journal of the National Kidney Foundation, 2001, Volume: 38, Issue:4 Suppl 4

Topics: Adrenergic Agents; Autonomic Nervous System; Caffeine; Carnitine; Ephedrine; Fludrocortisone; Hemodiafiltration; Humans; Hypertrophy, Left Ventricular; Hypotension; Kidney Failure, Chronic; Midodrine; Renal Dialysis; Risk Factors; Selective Serotonin Reuptake Inhibitors; Sertraline

2001

Other Studies

2 other study(ies) available for fludrocortisone and Hypertrophy, Left Ventricular

Article	Year
Reversible cardiomyopathy associated with autoimmune polyendocrine syndrome type II. Internal medicine (Tokyo, Japan), 2013, Volume: 52, Issue:9 Topics: Adult; Cardiomyopathies; Delayed Diagnosis; Female; Fludrocortisone; Hormone Replacement Therapy; Humans; Hypertrophy, Left Ventricular; Polyendocrinopathies, Autoimmune; Prednisolone; Remission Induction; Thyroxine; Ultrasonography; Ventricular Dysfunction, Left	2013
Hypertensive cardiovascular damage in patients with primary autonomic failure. Lancet (London, England), 2000, Feb-26, Volume: 355, Issue:9205 Topics: Autonomic Nervous System Diseases; Blood Pressure; Case-Control Studies; Female; Fludrocortisone; Humans; Hypertension; Hypertrophy, Left Ventricular; Hypotension, Orthostatic; Male; Middle Aged; Mineralocorticoids; Supine Position	2000

Article

Year

Reversible cardiomyopathy associated with autoimmune polyendocrine syndrome type II.

Internal medicine (Tokyo, Japan), 2013, Volume: 52, Issue:9

Topics: Adult; Cardiomyopathies; Delayed Diagnosis; Female; Fludrocortisone; Hormone Replacement Therapy; Humans; Hypertrophy, Left Ventricular; Polyendocrinopathies, Autoimmune; Prednisolone; Remission Induction; Thyroxine; Ultrasonography; Ventricular Dysfunction, Left

2013

Hypertensive cardiovascular damage in patients with primary autonomic failure.

Lancet (London, England), 2000, Feb-26, Volume: 355, Issue:9205

Topics: Autonomic Nervous System Diseases; Blood Pressure; Case-Control Studies; Female; Fludrocortisone; Humans; Hypertension; Hypertrophy, Left Ventricular; Hypotension, Orthostatic; Male; Middle Aged; Mineralocorticoids; Supine Position

2000